Most Recent
Full Court puts injector pen patent appeal on fast track
The Full Federal Court has expedited an appeal filed Christmas Eve by Sanofi-Aventis of a ruling that denied its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
Sandoz appeals loss in 15-year battle over Lexapro patent
Generic drug maker Sandoz is challenging a ruling that it infringed a patent behind Lundbeck's blockbuster antidepressant Lexapro, reviving a 15-year fight over the lucrative intellectual property.
Sanofi takes another stab at injunction in injector pen patent case
French pharmaceutical giant Sanofi has appealed a judge's ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
Ethicon wants class closure order in pelvic mesh case
Johnson & Johnson unit Ethicon is seeking a class closure order in the pelvic mesh class action, as the company prepares to enter mediation.
Full Court tosses ACCC appeal in Medibank disclosure case
The Australian Competition and Consumer Commission has lost an appeal of a ruling that dismissed its case over allegedly inadequate disclosures by private health insurer Medibank relating to member benefits.
Teva files challenge to Boehringer inhaler capsule patent
Generic drug giant Teva has filed a lawsuit seeking to have German pharmaceutical company Boehringer's patent for an inhalation capsule, which is used to deliver the active drug in its blockbuster Spiriva asthma inhaler, declared invalid.
Sanofi denied injunction in injector pen patent dispute
A judge has denied Sanofi's bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established a strong enough case of infringement to justify granting the injunction.
Judge OKs social media-only opt out notice in breast implant class action
A judge overseeing a class action against The Cosmetic Institute over allegedly botched breast implants has agreed to an opt out notice that will be sent to class members only through Facebook and Instagram.
Commonwealth slams Otsuka’s ‘inconsistent’ defences in Abilify patent case
The Commonwealth has urged the court to strike out the "inconsistent" pleadings of pharmaceutical firms Otsuka and Bristol-Myers Squibb in a patent case over the antipsychotic drug Abilify, calling them a "scandal" which could bring disrepute to the administration of justice.
B. Braun launches appeal in IV catheter patent case
Medical device maker B. Braun Melsungen is appealing a ruling that invalidated its intravenous catheter patents and dismissed allegations of infringement against rival Becton Dickinson.